Tag: Prescription Drugs
Exenatide, Pioglitazone Effective for Poorly Controlled T2DM
Findings in patients with long-standing poorly controlled type 2 diabetes on metformin, sulfonylurea
Extending Rx Exclusivity Could Boost Study for Rare Diseases
Substantial compensation to many drug manufacturers, especially for top-selling products
Experimental Drug May Simplify Macular Degeneration Treatment
Animal tests showed fewer injections needed to treat age-related macular degeneration
Syphilis Risk May Be Higher in HIV Patients on Antiretrovirals
Medications may raise susceptibility to bacterium that causes the sexually transmitted disease
Modest Links for Systemic Medication Use, IOP in Glaucoma
Systemic β-blocker use linked to lower IOP; ACEI, ARB, statin, sulfonylurea linked to higher IOP
Cognitive Stress Reduces Levodopa Effect in Parkinson’s
Levodopa effect significantly smaller during cognitive co-activation than during rest
Tetracycline + Colchicine Effective in Hidradenitis Suppurativa
Combination treatment effective for disease control with signs of improvement at three months
β-Blockers Linked to Reduced Mortality in HFrEF, A-Fib
Reduction in all-cause mortality, but not hospitalization, regardless of pattern, burden of a-fib
177Lu-Dotatate Ups PFS in Midgut Neuroendocrine Tumors
Longer progression-free survival compared to high-dose octreotide long-acting repeatable
Excessive FDA Regulation Driving High Drug Prices
First-in-class drugs are fast-tracked while follow-on drugs can take up to 15 years to be approved
